Pericapsular Nerve Group Block reduces post-operative pain in hip arthroscopy for femoroacetabular impingement surgery: A prospective randomized controlled clinical trial
Not Applicable
- Conditions
- M24.9Joint derangement, unspecified
- Registration Number
- DRKS00028506
- Lead Sponsor
- ARCUS Klinik Pforzheim
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Patients older than 18 years
primary hip arthroscopy with untreated FAIS
voluntary participation
Exclusion Criteria
Patients younger than 18 years
no voluntary patricipation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method postoperative pain level
- Secondary Outcome Measures
Name Time Method complications (a.e. falls)<br>need for additional pain medication
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are targeted by Pericapsular Nerve Group Block in hip arthroscopy for femoroacetabular impingement?
How does Pericapsular Nerve Group Block compare to traditional analgesics in post-operative pain management for hip surgeries?
Are there specific biomarkers that predict optimal patient response to PENG block in femoroacetabular impingement procedures?
What are the potential adverse events associated with Pericapsular Nerve Group Block in hip arthroscopy and how are they managed?
What combination therapies or alternative nerve blocks are being explored alongside PENG for enhanced post-operative pain relief in hip surgery?